Prevent Mix-Ups With Amphotericin B Shortages

Amphotericin B lipid complex (ABLC) continues to face shortages...without an estimated release date.

The shortage is ongoing since 2022...due to manufacturing issues.

Amphotericin B is often reserved for severe, life-threatening fungal infections (cryptococcal meningitis, invasive candidiasis, etc) that are refractory or resistant to other therapies (fluconazole, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote